Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Literature
1.
Kwon YD, Lee DW, Choi BJ, Lee JW, Kim DY (2012) Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws. Osteoporos Int. doi:10.​1007/​s00198-011-1882-9
2.
Subramanian G, Cohen HV, Quek SY (2011) A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide's potential role in its resolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112:744–753PubMedCrossRef
3.
Bertoldo F, Santini D, Lo Cascio V (2007) Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle. Nat Clin Pract Oncol 4:711–721PubMedCrossRef
4.
Allen MR, Burr DB (2009) The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 67:61–70PubMedCrossRef
5.
Otto S, Hafner S, Mast G et al (2010) Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle? J Oral Maxillofac Surg 68:1158–1161PubMedCrossRef
6.
Song K-E, Min Y-K, Lee J-K, Lee KB, Joo HJ, Kwack K-S, Chung Y-S (2008) A probable case of oral bisphosphonate-associated osteonecrosis of the jaw and recovery with parathyroid hormone treatment. Curr Ther Res 69:356–362CrossRef
7.
Kwon YD, Ohe JY, Kim DY, Chung DJ, Park YD (2011) Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers? Clin Oral Implants Res 22:100–105PubMedCrossRef
8.
Carlson ER, Basile JD (2009) The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 67:85–95PubMedCrossRef
Metadata
Title
Reply to Subramanian and Quek: Teriparatide’s role in the management of bisphosphonate-associated osteonecrosis of the jaw
Authors
Y.-D. Kwon
D.-Y. Kim
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 11/2012
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-012-1961-6

Other articles of this Issue 11/2012

Osteoporosis International 11/2012 Go to the issue

Original Article

The burden of illness of osteoporosis in Canada

Letter to the Editor

Calcium supplementation, renin, and vascular risk

Original Article

Association of MTHFR C667T polymorphism with bone mineral density and fracture risk: an updated meta-analysis

Original Article

The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action

Erratum

Erratum to: Autosomal recessive osteopetrosis: report of 41 novel mutations in the TCIRG1 gene and diagnostic implications

Original Article

Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland